Morgan Stanley says buy the dip on this software stock, calls for 50% surge

Morgan Stanley upgraded monday.com (MNDY) to Overweight from Equal Weight, while cutting its price target to $260 from $330, a level that still implies 49.3% upside from Monday's close. This move follows MNDY's nearly 30% stock plunge after Q2 results, which, despite beating revenue and earnings estimates, were overshadowed by mixed Q3 guidance and lackluster metrics. Analyst Josh Baer views the significant decline as a compelling entry point, asserting that market concerns regarding AI's impact on search advertising and the company's strategic shifts are "overblown" and that monday.com is well-positioned to navigate these changes.

Analysis

Morgan Stanley has upgraded monday.com (MNDY) to Overweight from Equal Weight, identifying a compelling entry point after the stock's nearly 30% plunge following its second-quarter earnings report. Despite the company beating revenue and earnings expectations, the market reacted negatively to mixed third-quarter guidance and what were described as lackluster metrics. The firm's analyst contends that this sell-off, which has contributed to a 40% decline over the last month and significant underperformance against the S&P 500, is an overreaction. While Morgan Stanley reduced its price target on MNDY to $260 from $330, the new target still suggests a 49.3% upside from its recent close. The analyst's bull thesis rests on the belief that market fears regarding AI's impact on search advertising and the company's performance marketing are "overblown." Furthermore, the company's strategic pivot to serve upmarket clients, expand its product suite, and adopt a sales-led growth model is viewed as a large, underpriced opportunity, despite inherent execution risks. This optimistic view is broadly supported by the wider analyst community, with LSEG data showing 22 of 24 analysts rating the stock a buy or strong buy.

Key Decisions for Investors

• Investors with a higher risk tolerance could consider the sharp pullback a strategic buying opportunity, aligning with Morgan Stanley's view that the stock's long-term growth potential is currently underpriced.
• Closely monitor upcoming earnings reports for evidence of successful execution in the company's strategic shifts, particularly its traction with upmarket clients and the effectiveness of its sales-led growth initiatives.
• Acknowledge the significant recent volatility and the market's strong negative reaction to Q3 guidance; the steep decline signals considerable investor skepticism that must be weighed against the bullish analyst consensus and revised price target.